Linkedin Facebook Twitter Youtube

23 Feb Cynata Therapeutics

Posted at 19:01h in by

Kilian Kelly, Ph.D., CEO

Oct. 10 | 4:45pm | Ecolab Life Sciences Ballroom 

Melbourne, Australia

(ASX:CYP)

Cynata Therapeutics Limited is a clinical stage stem cell and regenerative medicine company developing a therapeutic mesenchymal stem cell (MSC) platform technology, Cymerus™, utilizing induced pluripotent stem cells (iPSCs) as starting material. Cynata is the global leader in developing iPSC-derived cell therapies. A successful clinical trial in GvHD has been completed, meeting all safety and efficacy endpoints. The Company is undertaking clinical trials in diabetic foot ulcers and a Phase 3 clinical trial in osteoarthritis. A Phase 2 clinical trial in GvHD is expected to commence during 2023 (following IND clearance from the US FDA in 2022). The Cymerus technology addresses a critical shortcoming in conventional methods of production of MSCs for therapeutic use, which is the ability to achieve consistent, economic manufacture at commercial scale. Cymerus utilizes a proprietary process that is independent of donor limitations providing an “off-the-shelf” production platform for therapeutic product manufacture.

www.cynata.com 

 



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 10-12, 2023
Park Hyatt Aviara
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions